$4.490
-0.020 (-0.44%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ATHE Prediction & Forecast by Similar Chart Analysis
Alphio's ATHE stock price prediction model matches the current Alterity Therapeutics Limited tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.63 (+1.74%). The 1-week path is $4.61 (+1.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Alterity Therapeutics Limited Stock?
Alterity Therapeutics is a good buy right now due to its recent positive FDA feedback for ATH434, which supports its Phase 3 program, and the stock's current price of $4.51 is significantly lower than the analyst price targets, indicating potential upside. The RSI is at 44.707, suggesting the stock is not overbought, and the 20-day change is +2.15%, indicating a recent positive trend. However, the main risk is the negative earnings report which caused a 4.6% drop in market price.
ATHE stock price ended at $4.49 on Monday, after losing -0.44%
Alterity Therapeutics Limited (ATHE) last closed at $4.55, gaining +1.34%. These facts feed the 1-day and 1-week ATHE price prediction above.
Forecast Drivers
Alterity Therapeutics Limited (ATHE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ATHE, ranked by similarity.
Seasonality analysis for ATHE
Historically the probability of a positive September return for ATHE is 50.00%. June offers the highest probability of a positive month at 68.33%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ATHE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $5.69 | $6.04 | $6.76 | +32.69% |
| Oct 2026 | $4.20 | $4.88 | $5.44 | +7.21% |
| Nov 2026 | $4.99 | $5.39 | $6.43 | +18.40% |
| Dec 2026 | $4.13 | $4.94 | $5.55 | +8.65% |
In 2026, Alterity Therapeutics Limited (ATHE) is projected to range from $4.13 to $6.76.
Alterity Therapeutics Limited 2026 monthly forecast
In Sep 2026, Alterity Therapeutics Limited is projected to average $6.04, with a low of $5.69 and high of $6.76.
In Oct 2026, Alterity Therapeutics Limited is projected to average $4.88, with a low of $4.20 and high of $5.44.
In Nov 2026, Alterity Therapeutics Limited is projected to average $5.39, with a low of $4.99 and high of $6.43.
In Dec 2026, Alterity Therapeutics Limited is projected to average $4.94, with a low of $4.13 and high of $5.55.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.